Skip to NavigationSkip to content

academic research

Pharma R&D downsizing hits academic researchers

A survey of pharma’s research partnerships and funding of UK academics has raised concerns about the future of British science.

The ABPI’s biennial Industry/Academic Links Survey found that the number of industrial placements given to undergraduates has halved in four years, from 530 in 2007 to 268 in 2011.

Industrial placements are vital in helping undergraduates gain practical skills and knowledge of research, and their increasing rarity will make it harder for the UK to produce scientists with the right skills.

Pfizer teams up with University of California for drug discovery

Pfizer has signed a deal with the University of California to help expand its drug discovery and development programme.

The company will invest up to $50 million over the next five years toward the collaboration, with much of it going to support research programmes and potential milestone payments to University of California San Diego Health Sciences for successful projects.

The partnership includes dedicated lab space at Pfizer’s La Jolla research and development campus, which allow scientists from Pfizer and UC San Diego Health Sciences to work closely together.

Eisai extends neuroscience partnership with UCL

Eisai and University College London are to extend their partnership in neuroscience research.

The Japanese company’s Neuroscience Product Creation Unit has been working with University College London (UCL) since 1990, and the partners are now deepening their collaboration.

GSK and AZ collaborate on translational research centre

GSK said a collaborative approach would improve the changes of success in the challenging area of translating basic research discoveries into new medicines

The University of Manchester has teamed up with GSK and AstraZeneca to create the Manchester Collaborative Centre for Inflammation Research (MCCIR), aimed at establishing a world-leading translational centre for inflammatory diseases.

The project starts out with an initial investment of £5 million from each partner over a three year period, and will bring together scientists from the pharma industry and academia to collaborate on inflammation research and translational medicine.

GSK in manufacturing research collaboration with university

Research into a cutting-edge area of pharmaceutical manufacturing in the UK is to be supported by a new £51 million government investment.

GlaxoSmithKline is among the companies who will forge alliances with UK universities to develop specialist manufacturing technologies, as part of a drive to support the country’s manufacturing base.

UCB teams up with Harvard for CNS research

UCB has signed a new research collaboration with Harvard University that will focus on central nervous system and immunology therapies.

The Belgium-based company says it will bring its expertise on antibody generation and medicinal chemistry to the alliance, and will provide up to $6 million over two years to fund specific innovative research projects led by Harvard scientists.

The alliance will advance ongoing Harvard research projects along the drug development pathway, and aims to create a drug discovery bridge between industry and academia.

Roche forms translational medicine research hub

Basel University's Biozentrum
Basel University's Biozentrum, which focus on the investigation of biological nanomachines and communication systems in health and disease

Roche is linking up with Basel’s university and university hospital in a ‘strategic alliance’ that will establish and manage what the three Swiss parties call a translational medicine research hub.

This will involve attempting to translate research from preclinical and clinical studies into new or improved therapies for various conditions.

Bayer strikes R&D deal with Chinese university


Bayer has furthered its R&D expansion in China with an agreement to form a joint pharmaceutical research centre with Tsinghua University in Beijing.

Last month the German company unveiled plans to construct a 100 million-euro R&D centre in Beijing with the aim of forging collaborations with local academic researchers.

Mission Statement is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches